William Anderson
Profile
William N.
Anderson is currently the Chief Executive Officer at Bayer AG since 2023.
He is also serving as the Director at Chugai Pharmaceutical Co., Ltd. since 2019 and as a Director at Pharmaceutical Research & Manufacturers of America.
Previously, he held the position of Chief Executive Officer & Director at Genentech, Inc. He was also the Chief Executive Officer at Roche Pharmaceuticals, Inc. from 2019 to 2022 and at Roche Pharma (Schweiz) AG from 2019 to 2023.
Prior to that, he worked as the Vice President-Neurology Unit at Biogen, Inc. from 2004 to 2006.
Mr. Anderson completed his graduate degree from Massachusetts Institute of Technology and his undergraduate degree from The University of Texas at Austin.
William Anderson active positions
| Companies | Position | Start |
|---|---|---|
| CHUGAI PHARMACEUTICAL CO., LTD. | Director/Board Member | 01/03/2019 |
| BAYER AG | Chief Executive Officer | 01/06/2023 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Board Member | - |
Former positions of William Anderson
| Companies | Position | End |
|---|---|---|
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Chief Executive Officer | 01/01/2023 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Chief Executive Officer | 31/12/2022 |
| BIOGEN INC. | Director of Finance/CFO | 01/01/2004 |
Genentech, Inc.
Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | Chief Executive Officer | - |
Training of William Anderson
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
- Stock Market
- Insiders
- William Anderson
















